Enhanced performance of impedimetric immunosensors to detect SARS-CoV-2 with bare gold nanoparticles and graphene acetic acid

Immunosensors based on electrical impedance spectroscopy allow for label-free, real-time detection of biologically relevant molecules and pathogens, without requiring electro-active materials. Here, we investigate the influence of bare gold nanoparticles (AuNPs), synthesized via laser ablation in so...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Talanta (Oxford) 2025-01, Vol.281, p.126903, Article 126903
Hauptverfasser: Hensel, Rafael C., Di Vizio, Biagio, Materòn, Elsa M., Shimizu, Flávio M., Angelim, Monara Kaelle S.C., de Souza, Gabriela F., Módena, José L.P., Moraes-Vieira, Pedro M.M., de Azevedo, Ricardo B., Litti, Lucio, Agnoli, Stefano, Casalini, Stefano, Oliveira Jr, Osvaldo N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Immunosensors based on electrical impedance spectroscopy allow for label-free, real-time detection of biologically relevant molecules and pathogens, without requiring electro-active materials. Here, we investigate the influence of bare gold nanoparticles (AuNPs), synthesized via laser ablation in solution, on the performance of an impedimetric immunosensor for detecting severe acute respiratory syndrome coronavirus (SARS-CoV-2). Graphene acetic acid (GAA) was used in the active layer for immobilizing anti-SARS-CoV-2 antibodies, owing to its high density of carboxylic groups. Immunosensors incorporating AuNPs exhibited superior performance compared to those relying solely on GAA, achieving a limit of detection (LoD) of 3 x 10−20 g/mL to detect the Spike Receptor Binding Domain (RBD) protein of SARS-CoV-2 and of 2 PFU/mL for inactivated virus. Moreover, these immunosensors presented high selectivity against the H1N1 influenza virus. We anticipate that this platform will be versatile and applicable in the early diagnosis of various diseases and viral infections, thereby facilitating Point-of-Care testing. [Display omitted] •AuNP-enhanced immunosensors detect SARS-CoV-2 RBD protein at 3x10−20 g/mL.•Impedimetric immunosensor based on AuNP and GAA detects SARS-CoV-2 at 2 PFU/mL.•High selectivity against H1N1 virus, promising for versatile PoC diagnostics.
ISSN:0039-9140
1873-3573
1873-3573
DOI:10.1016/j.talanta.2024.126903